Unexplained weight loss (UWL) continues to pose diagnostic challenges in clinical practice. Despite its potential implications for serious underlying conditions, it often remains an enigma. This article aims to provide a comprehensive approach to diagnosing unexplained weight loss.
Initial evaluation should focus on a detailed medical history, including dietary habits, lifestyle changes, and medication use. Physical examination should be comprehensive, focusing on signs of malnutrition or potential malignancy. Initial diagnostic tests should include complete blood count, metabolic panel, thyroid function tests, and urinalysis. If these are non-revealing, more specific tests based on clinical suspicion should be considered.
Common causes of UWL include malignancies, gastrointestinal disorders, endocrine disorders, infections, and psychiatric conditions. Malignancies and gastrointestinal disorders often present with additional symptoms such as pain or altered bowel habits. Endocrine disorders like hyperthyroidism and diabetes may present with symptoms such as palpitations or polyuria. Infections such as tuberculosis or HIV may be associated with fever and night sweats. Psychiatric conditions like depression or anorexia nervosa often present with mood changes or altered eating habits.
The diagnostic approach should be guided by the patient's history, physical examination, and initial test results. If a specific cause is not identified, a stepwise approach should be adopted, starting with the most likely causes based on the patient's age, gender, and risk factors. If initial tests are non-revealing, more specific tests should be considered based on clinical suspicion.
Management should be directed towards the underlying cause if identified. If no specific cause is identified, symptomatic management and close follow-up should be recommended. Follow-up should include regular weight checks and repeat evaluations if weight loss continues or new symptoms develop.
Unexplained weight loss remains a diagnostic enigma in clinical practice. A comprehensive approach, focusing on detailed history, physical examination, and systematic diagnostic testing, can help decipher this enigma. Management should be directed towards the underlying cause if identified, with close follow-up if no specific cause is found.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation